OAB-062: Efficacy and safety of cilta-cel in patients with progressive multiple myeloma after exposure to BCMA-targeting bispecific antibody treatment

Autor:	Jesus San-Miguel, María-Victoria Mateos, Yael C. Cohen, Paula Rodriguez-Otero, Bruno Paiva, Niels W.C.J. van de Donk, Thomas Martin, Mohammad Abu-Zaid, Christina Corsale, Jordan M. Schecter, Kevin C. De Braganca, Helen Varsos, William Deraedt, Liwei Wang, Tito Roccia, Claire Li, Pankaj Mistry, Xiaoying Xu, Enrique Zudaire, Muhammad Akram, Tonia Nesheiwat, Lida Pacaud, Irit Avivi, Adam D. Cohen
Rok vydání:	2022
Předmět:	Cancer Research Oncology Hematology
Zdroj:	Clinical Lymphoma Myeloma and Leukemia. 22:S35-S36
ISSN:	2152-2650
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::e342f772e668504069118a4ff16d9d32 https://doi.org/10.1016/s2152-2650(22)00330-5 Zobrazit plný text záznamu Full Text from ScienceDirect